1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Dietary Supplements Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Dietary Supplements Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Popularity of Dietary Supplements
- 5.1.2 Rising Number of Strategic Initiatives by Key Players to Expand Product Portfolio
5.2 Market Opportunities
- 5.2.1 Increasing Preference for Dietary Supplements with Organic and Vegan Claims
5.3 Future Trends
- 5.3.1 Growing Popularity of Beauty Supplements
5.4 Impact of Drivers and Restraints
6. Europe Dietary Supplements Market Regional Analysis
6.1 Europe Dietary Supplements Market Overview
6.2 Europe Dietary Supplements Market Revenue 2021-2031 (US$ Billion)
6.3 Europe Dietary Supplements Market Forecast Analysis
7. Europe Dietary Supplements Market Analysis – by Type
7.1 Vitamins
- 7.1.1 Overview
- 7.1.2 Vitamins: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
7.2 Minerals
- 7.2.1 Overview
- 7.2.2 Minerals: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
7.3 Proteins and Amino Acids
- 7.3.1 Overview
- 7.3.2 Proteins and Amino Acids: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
7.4 Probiotics
- 7.4.1 Overview
- 7.4.2 Probiotics: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
7.5 Blends
- 7.5.1 Overview
- 7.5.2 Blends: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
8. Europe Dietary Supplements Market Analysis – by Form
8.1 Tablets
- 8.1.1 Overview
- 8.1.2 Tablets: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
8.2 Capsules and Softgels
- 8.2.1 Overview
- 8.2.2 Capsules and Softgels: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
8.3 Powders
- 8.3.1 Overview
- 8.3.2 Powders: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
9. Europe Dietary Supplements Market Analysis – by Distribution Channel
9.1 Supermarkets and Hypermarkets
- 9.1.1 Overview
- 9.1.2 Powders: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
9.2 Specialty Stores
- 9.2.1 Overview
- 9.2.2 Powders: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
9.3 Online Retail
- 9.3.1 Overview
- 9.3.2 Powders: Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
10. Europe Dietary Supplements Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Dietary Supplements Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.1.1.1 Europe Dietary Supplements Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.1.1 UK: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.1.2 UK: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.1.3 UK: Europe Dietary Supplements Market Breakdown, by Distribution Channel
- 10.1.1.2 Germany:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.2.1 Germany: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.2.2 Germany: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.2.3 Germany: Europe Dietary Supplements Market Breakdown, by Distribution Channel
- 10.1.1.3 France:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.3.1 France: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.3.2 France: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.3.3 France: Europe Dietary Supplements Market Breakdown, by Distribution Channel
- 10.1.1.4 Russia:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.4.1 Russia: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.4.2 Russia: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.4.3 Russia: Europe Dietary Supplements Market Breakdown, by Distribution Channel
- 10.1.1.5 Italy:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.5.1 Italy: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.5.2 Italy: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.5.3 Italy: Europe Dietary Supplements Market Breakdown, by Distribution Channel
- 10.1.1.6 Rest of Europe:
Europe Dietary Supplements Market – Revenue and Forecast to 2031 (US$ Billion)
- 10.1.1.6.1 Rest of Europe: Europe Dietary Supplements Market Breakdown, by Type
- 10.1.1.6.2 Rest of Europe: Europe Dietary Supplements Market Breakdown, by Form
- 10.1.1.6.3 Rest of Europe: Europe Dietary Supplements Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Dietary Supplements Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Glanbia Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Herbalife Nutrition Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Amway Corp
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bayer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Arkopharma SAS
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Pfizer Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Otsuka Holdings Co Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 GSK Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 NOW Health Group Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Nestle Health Science SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights